We summarize advances in research on urate -lowering drugs including urate transporter inhibitors, xanthine oxidase inhibitors as well as novel urate -lowering drugs, and evaluate the effect of urate-lowering therapy on the rate of hyperuricaemia-related diseases
What to Expect During PT 141 Treatment Patients receive a clinical assessment before starting PT 141
Within a few years, patients and clinicians will have a menu of options ranging from single-receptor oral pills to triple-receptor injectable agonists, each with distinct efficacy, safety, and convenience profiles
Patient Information for Synjardy SYNJARDY (sin-JAR-dee) (empagliflozin and metformin hydrochloride tablets), for oral use and SYNJARDY XR (sin-JAR-dee XR) (empagliflozin and metformin hydrochloride extended-release tablets), for oral use What is the most important information I should know about SYNJARDY or SYNJARDY XR
The limited available data with sitagliptin in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage
The sodium excretion, glycemic correction, and gastric slowdown causing the headaches are the same mechanisms driving weight loss and metabolic improvement
